Raised serum thiobarbituric acid reactive substance levels in malaria

Area of Science:

• Biochemistry
• Pathology
• Infectious Diseases

Background:

• Malaria is a significant global health burden, caused by Plasmodium parasites.
• Oxidative stress plays a role in the pathogenesis of malaria.
• Lipid peroxidation is a key indicator of oxidative damage.

Purpose of the Study:

• To quantify serum lipid peroxidation levels in patients with malaria.
• To compare lipid peroxidation between different malaria types (Falciparum vs. Vivax).
• To assess the correlation between lipid peroxidation and malaria severity.

Main Methods:

• Serum samples were collected from 62 Falciparum malaria patients, 15 Vivax malaria patients, and 25 healthy controls.
• Lipid peroxidation was measured using the thiobarbituric acid reactive substances (TBARS) assay.
• Colorimetric methods were employed for TBARS quantification.

Main Results:

• Mean serum TBARS levels were elevated in malaria patients (3.58 ± 1.35 nmol/ml) compared to controls (1.5 ± 0.29 nmol/ml).
• Falciparum malaria patients exhibited significantly higher TBARS levels (3.58 ± 1.35 nmol/ml) than Vivax malaria patients (1.21 ± 0.2 nmol/ml).
• Complicated Falciparum malaria cases showed markedly higher TBARS levels (4.2 ± 1.03 nmol/ml) than uncomplicated cases (2.01 ± 0.61 nmol/ml), and levels were highest in non-survivors.

Conclusions:

• Serum lipid peroxidation is significantly elevated in malaria patients, particularly with Falciparum malaria.
• Increased TBARS levels correlate with malaria severity and poorer outcomes.
• Lipid peroxidation is a potential biomarker for assessing malaria-associated oxidative stress and prognosis.